Advanced search
Publication Cover
Baylor University Medical Center Proceedings
The peer-reviewed journal of Baylor Scott & White Health
Volume 33, 2020 - Issue 3
Submit an article Journal homepage
71
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Hemophagocytic lymphohistiocytosis in adults

Yadav PandeyDepartment of Hematology and Oncology, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0003-2307-7310
, MDORCID Icon,
Dinesh AtwalDepartment of Hematology and Oncology, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas;
, MD,
Manojna KondaDepartment of Hematology and Oncology, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas; ORCID Iconhttp://orcid.org/0000-0001-8631-741X
, MDORCID Icon,
Milan BimaliDepartment of Biostatistics, University of Arkansas for Medical Sciences, Little Rock, Arkansas;
, PhD,
Derek MiddletonDepartment of Hematology and Oncology, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas;
, MD,
Naveen YarlagaddaDepartment of Hematology and Oncology, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas;
, MD,
Belal FirwanaHeartland Cancer Research NCI Community Oncology Research Program, Missouri Baptist Medical Center, St. Louis, Missouri
, MD &
Appalanaidu SasapuDepartment of Hematology and Oncology, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas;
, MD show all
Pages 326-330 | Received 21 Jan 2020, Accepted 27 Feb 2020, Published online: 03 Apr 2020

  • Filipovich A, McClain K, Grom A. Histiocytic disorders: recent insights into pathophysiology and practical guidelines. Biol Blood Marrow Transplant. 2010;16(1):S82–S89. doi:10.1016/j.bbmt.2009.11.014.
  • George MR. Hemophagocytic lymphohistiocytosis: review of etiologies and management. J Blood Med. 2014;5:69–86. doi:10.2147/JBM.S46255.
  • Jordan MB, Allen CE, Weitzman S, Filipovich AH, McClain KL. How I treat hemophagocytic lymphohistiocytosis. Blood. 2011;118(15):4041–4052. doi:10.1182/blood-2011-03-278127.
  • Machaczka M, Vaktnas J, Klimkowska M, Hagglund H. Malignancy-associated hemophagocytic lymphohistiocytosis in adults: a retrospective population-based analysis from a single center. Leuk Lymphoma. 2011;52(4):613–619. doi:10.3109/10428194.2010.551153.
  • Clementi R, Emmi L, Maccario R, et al. Adult onset and atypical presentation of hemophagocytic lymphohistiocytosis in siblings carrying PRF1 mutations. Blood. 2002;100(6):2266–2267. doi:10.1182/blood-2002-04-1030.
  • Arca M, Fardet L, Galicier L, et al. Prognostic factors of early death in a cohort of 162 adult haemophagocytic syndrome: impact of triggering disease and early treatment with etoposide. Br J Haematol. 2015;168(1):63–68. doi:10.1111/bjh.13102.
  • Hayden A, Park S, Giustini D, Lee AYY, Chen L. Hemophagocytic syndromes (HPSs) including hemophagocytic lymphohistiocytosis (HLH) in adults: A systematic scoping review. Blood Rev. 2016;30(6):411–420. doi:10.1016/j.blre.2016.05.001.
  • Fardet L, Galicier L, Lambotte O, et al. Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome. Arthritis Rheumatol (Hoboken, NJ). 2014;66(9):2613–2620. doi:10.1002/art.38690.
  • Hejblum G, Lambotte O, Galicier L, et al. A web-based Delphi study for eliciting helpful criteria in the positive diagnosis of hemophagocytic syndrome in adult patients. PLoS One. 2014;9(4):e94024–e94024. doi:10.1371/journal.pone.0094024.
  • Henter J-I, Horne A, Arico M, et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48(2):124–131. doi:10.1002/pbc.21039.
  • Tamamyan GN, Kantarjian HM, Ning J, et al. Malignancy-associated hemophagocytic lymphohistiocytosis in adults: relation to hemophagocytosis, characteristics, and outcomes. Cancer. 2016;122(18):2857–2866. doi:10.1002/cncr.30084.
  • Schram AM, Campigotto F, Mullally A, et al. Marked hyperferritinemia does not predict for HLH in the adult population. Blood. 2015;125(10):1548–1552. doi:10.1182/blood-2014-10-602607.
  • Hibi S, Ikushima S, Fujiwara F, et al. Serum and urine beta-2-microglobulin in hemophagocytic syndrome. Cancer. 1995;75(7):1700–1705. doi:10.1002/1097-0142(19950401)75:7<1700::AID-CNCR2820750722>3.0.CO;2-D.
  • Janka G. Hemophagocytic lymphohistiocytosis: when the immune system runs amok. Klin Padiatr. 2009;221(05):278–285. doi:10.1055/s-0029-1237386.
  • Ramos-Casals M, Brito-Zeron P, Lopez-Guillermo A, Khamashta MA, Bosch X. Adult haemophagocytic syndrome. Lancet. 2014;383(9927):1503–1516. doi:10.1016/S0140-6736(13)61048-X.
  • Riviere S, Galicier L, Coppo P, et al. Reactive hemophagocytic syndrome in adults: a retrospective analysis of 162 patients. Am J Med. 2014;127(11):1118–1125. doi:10.1016/j.amjmed.2014.04.034.
  • Zhang Z, Wang J, Ji B, et al. Clinical presentation of hemophagocytic lymphohistiocytosis in adults is less typical than in children. Clinics. 2016;71(4):205–209. doi:10.6061/clinics/2016(04)05.
  • Henter JI, Arico M, Egeler RM, et al. HLH-94: a treatment protocol for hemophagocytic lymphohistiocytosis. HLH Study Group of the Histiocyte Society. Med Pediatr Oncol. 1997;28(5):342–247. doi:10.1002/(SICI)1096-911X(199705)28:5<342::AID-MPO3>3.0.CO;2-H.
  • Parikh SA, Kapoor P, Letendre L, Kumar S, Wolanskyj AP. Prognostic factors and outcomes of adults with hemophagocytic lymphohistiocytosis. Mayo Clin Proc. 2014;89(4):484–492. doi:10.1016/j.mayocp.2013.12.012.
  • Shin H-J, Chung JS, Lee J-J, et al. Treatment outcomes with CHOP chemotherapy in adult patients with hemophagocytic lymphohistiocytosis. J Korean Med Sci. 2008;23(3):439–444. doi:10.3346/jkms.2008.23.3.439.
  • Fu L, Wang J, Wei N, et al. Allogeneic hematopoietic stem-cell transplantation for adult and adolescent hemophagocytic lymphohistiocytosis: a single center analysis. Int J Hematol. 2016;104(5):628–635. doi:10.1007/s12185-016-2062-7.
  • Lounder DT, Bin Q, de Min C, Jordan MB. Treatment of refractory hemophagocytic lymphohistiocytosis with emapalumab despite severe concurrent infections. Blood Adv. 2019;3(1):47–50. doi:10.1182/bloodadvances.2018025858.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.